CYTOREX

Cytorex Biosciences, Inc. is a privately held biotechnology research and development company headquartered in Florida with Research and Development based in Texas. It is the intellectual owner of the Cytoreg® ionic therapeutic technology platform. This chemical-based technology is based on the therapeutic use of ions and makes it possible to obtain, among the various therapeutic agents to treat various pathologies, a novel ionic therapeutic agent for the treatment of brain tumors of the Glioblastoma Multiforme (GBM) type... Leveraging decades of research and development, Cytorex's technology platform, takes advantage of the low molecular weight of its ionic therapeutic agent to cross the blood-brain barrier and facilitate the treatment of this type of brain tumor through multiple concurrent mechanisms of action provided by each ion present in the agent.

Also known as: Cytorex Biosciences, Cytorex Biosciences Inc.

Primary location: Florida United States